A Silicon Valley start-up with big-name backers has announced plans to make cost a virtual non-issue for women who want to get genetic testing for breast and ovarian cancer.
The company plans to charge less than one tenth the price of tests currently on the market.
Silicon Valley Correspondent Rachel Silverman has details.
IN: “The start-up”
OUT: SOC
DUR: 32 seconds